Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
---|---|---|---|---|---|
Udayan Guha | Chief Medical Officer | Feb 1, 2025 | |||
Anne E. Borgman | Director | Jun 20, 2024 | |||
John Houston | Director | Jun 20, 2024 | |||
Timothy Mayer | Chief Operating Officer | Jan 31, 2025 | |||
Linda Liu | SVP, Research | Jan 31, 2022 | |||
Sourav Kundu | Sr VP, Dev. & Mfg. | Jan 31, 2025 | |||
Han Myint | Chief Medical Officer | Mar 29, 2024 | |||
Steven P. Cobourn | Chief Financial Officer | Jan 31, 2025 | |||
Kabakoff David S | Director | Jun 20, 2024 | |||
Elaine V. Jones | Director | Jun 20, 2024 | |||
Ellen Feigal | Director | Jun 20, 2024 | |||
Michael Richman | President & CEO, Director | Jan 31, 2025 | |||
Stella Xu | Director | Jun 24, 2021 | |||
Garry A. Nicholson | Director | Jun 22, 2023 | |||
Kevin G. Shaw | Sr VP, General Counsel | Jan 31, 2025 | |||
Sol Langermann | Chief Scientific Officer | Jan 31, 2025 | |||
Stephen W. Webster | Director | Jun 20, 2024 | |||
Chau Q. Khuong | Director | Jun 22, 2023 |
Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
---|